Formaldehyde in brain: An overlooked player in neurodegeneration?

Journal of Neurochemistry

Volumn 127, Issue 1, 2013, Pages 7-21

  Tulpule, Ketki ^a   Dringen, Ralf ^b  

^a INDIAN INSTITUTE OF SCIENCE EDUCATION AND RESEARCH   (India)

^b UNIVERSITY OF BREMEN   (Germany)

Author keywords

formaldehyde; glutathione; glycolysis; metabolism; neurodegeneration; neurotoxicity

Indexed keywords

ALCOHOL DEHYDROGENASE; AMINE OXIDASE (COPPER CONTAINING); ARYLDIALKYLPHOSPHATASE 1; CATALASE; CYTOCHROME C OXIDASE; FORMALDEHYDE; GLUTATHIONE; GLYCOLYTIC ENZYME; HISTONE DEMETHYLASE; HYDROXYL RADICAL; MESSENGER RNA; MULTIDRUG RESISTANCE PROTEIN 1; MYELIN BASIC PROTEIN; PROTEIN BAX; PROTEIN BCL 2; PROTEIN PFKFB3; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE; TAU PROTEIN; TYROSINE 3 MONOOXYGENASE; UNCLASSIFIED DRUG;

ADH1 GENE; ALCOHOL CONSUMPTION; ALCOHOL OXIDATION; ALZHEIMER DISEASE; AMYOTROPHIC LATERAL SCLEROSIS; BIOACCUMULATION; BLOOD BRAIN BARRIER; BRAIN CELL; BRAIN DAMAGE; BRAIN LEVEL; BRAIN METABOLISM; COGNITIVE DEFECT; CYTOTOXICITY; ENVIRONMENTAL EXPOSURE; ENZYME ACTIVITY; ENZYME INACTIVATION; GENE; GENE EXPRESSION; GLUTATHIONE METABOLISM; GLYCOLYSIS; HUMAN; HYDROLYSIS; INTRACELLULAR SIGNALING; LACTIC ACIDOSIS; LONG TERM EXPOSURE; METABOLIC DISORDER; MITOCHONDRIAL RESPIRATION; MULTIPLE SCLEROSIS; NERVE DEGENERATION; NEUROPATHOLOGY; NEUROTOXICITY; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN MODIFICATION; PROTEIN TRANSPORT; REVIEW; RISK FACTOR;

FORMALDEHYDE; GLUTATHIONE; GLYCOLYSIS; METABOLISM; NEURODEGENERATION; NEUROTOXICITY;

ANIMALS; BRAIN; FORMALDEHYDE; GLUTATHIONE; GLYCOLYSIS; HUMANS; NEURODEGENERATIVE DISEASES; OXIDATION-REDUCTION;

EID: 84884910176     PISSN: 00223042     EISSN: 14714159     Source Type: Journal    
DOI: 10.1111/jnc.12356     Document Type: Review

References (186)

1. Ahmed A. E., and, Ahmed M. W., (1978) Metabolism of dihalomethanes to formaldehyde and inorganic halide II. Studies on the mechanism of the reaction. Biochem. Pharmacol. 27, 2021-2025.
2. Airas L., Mikkola J., Vainio J. M., Elovaara I., and, Smith D. J., (2006) Elevated serum soluble vascular adhesion protein-1 (VAP-1) in patients with active relapsing remitting multiple sclerosis. J. Neuroimmunol. 177, 132-135.
3. Alnouti Y., and, Klaassen C. D., (2008) Tissue distribution, ontogeny, and regulation of aldehyde dehydrogenase (Aldh) enzymes mRNA by prototypical microsomal enzyme inducers in mice. Toxicol. Sci. 101, 51-64.
4. Anthony T. E., and, Heintz N., (2007) The folate metabolic enzyme ALDH1L1 is restricted to the midline of the early CNS, suggesting a role in human neural tube defects. J. Comp. Neurol. 500, 368-383.
5. Aslan H., Songur A., Tunc A. T., Ozen O. A., Bas O., Yagmurca M., Turgut M., Sarsilmaz M., and, Kaplan S., (2006) Effects of formaldehyde exposure on granule cell number and volume of dentate gyrus: a histopathological and stereological study. Brain Res. 1122, 191-200.
6. Belkacemi A., and, Ramassamy C., (2012) Time sequence of oxidative stress in the brain from transgenic mouse models of Alzheimer's disease related to the amyloid-β cascade. Free Radic. Biol. Med. 52, 593-600.
7. Bennani-Baiti I. M., Machado I., Llombart-Bosch A., and, Kovar H., (2012) Lysine-specific demethylase 1 (LSD1/KDM1A/AOF2/BHC110) is expressed and is an epigenetic drug target in chondrosarcoma, Ewing's sarcoma, osteosarcoma, and rhabdomyosarcoma. Hum. Pathol. 43, 1300-1307.
8. Berkich D. A., Ola M. S., Cole J., Sweatt A. J., Hutson S. M., and, LaNoue K. F., (2007) Mitochondrial transport proteins of the brain. J. Neurosci. Res. 85, 3367-3377.
9. Bolaños J. P., Almeida A., and, Moncada S., (2010) Glycolysis: a bioenergetic or a survival pathway?. Trends Biochem. Sci. 35, 145-149.
10. Boomsma F., de Kam P. J., Tjeerdsma G., van den Meiracker A. H., and, van Veldhuisen D. J., (2000) Plasma semicarbazide-sensitive amine oxidase (SSAO) is an independent prognostic marker for mortality in chronic heart failure. Eur. Heart J. 21, 1859-1863.
11. Boomsma F., Hut H., Bagghoe U., van der Houwen A., and, van den Meiracker A., (2005) Semicarbazide-sensitive amine oxidase (SSAO): from cell to circulation. Med. Sci. Monit. 11, RA122-RA126.
12. Boumezbeur F., Mason G. F., de Graaf R. A., Behar K. L., Cline G. W., Shulman G. I., Rothman D. L., and, Petersen K. F., (2010) Altered brain mitochondrial metabolism in healthy aging as assessed by in vivo magnetic resonance spectroscopy. J. Cereb. Blood Flow Metab. 30, 211-221.
13. Burg D., Wielinga P., Zelcer N., Saeki T., Mulder G. J., and, Borst P., (2002) Inhibition of the multidrug resistance protein 1 (MRP1) by peptidomimetic glutathione-conjugate analogs. Mol. Pharmacol. 62, 1160-1166.
14. Cahoy J. D., Emery B., Kaushal A., et al,. (2008) A transcriptome database for astrocytes, neurons, and oligodendrocytes: a new resource for understanding brain development and function. J. Neurosci. 28, 264-278.
15. +-dependent dehydrogenases in rat nasal mucosal homogenates. Biochem. Pharmacol. 33, 1137-1142.
16. Cheng X., and, Zhang X., (2007) Structural dynamics of protein lysine methylation and demethylation. Mutat. Res. 618, 102-115.
17. Cloos P. A., Christensen J., Agger K., and, Helin K., (2008) Erasing the methyl mark: histone demethylases at the center of cellular differentiation and disease. Genes Dev. 22, 1115-1140.
18. Cole S. P. C., and, Deeley R. G., (2006) Transport of glutathione and glutathione conjugates by MRP1. Trends Pharmacol. Sci. 27, 438-446.
19. Cook R. J., Champion K. M., and, Giometti C. S., (2001) Methanol toxicity and formate oxidation in NEUT2 mice. Arch. Biochem. Biophys. 393, 192-198.
20. Davis M. J., Iancu O. D., Acher F. C., Stewart B. M., Eiwaz M. A., Duvoisin R. M., and, Raber J., (2013) Role of mGluR4 in acquisition of fear learning and memory. Neuropharmacology 66, 365-372.
21. Debernardi R., Pierre K., Lengacher S., Magistretti P. J., and, Pellerin L., (2003) Cell-specific expression pattern of monocarboxylate transporters in astrocytes and neurons observed in different mouse brain cortical cell cultures. J. Neurosci. Res. 73, 141-155.
22. Deeley R. G., and, Cole S. P., (2006) Substrate recognition and transport by multidrug resistance protein 1 (ABCC1). FEBS Lett. 580, 1103-1111.
23. Dhareshwar S. S., and, Stella V. J., (2008) Your prodrug releases formaldehyde: should you be concerned? No! J. Pharm. Sci. 97, 4184-4193.
24. Dicker E., and, Cederbaum A. I., (1984) Inhibition of the oxidation of acetaldehyde and formaldehyde by hepatocytes and mitochondria by crotonaldehyde. Arch. Biochem. Biophys. 234, 187-196.
25. Dringen R., and, Hamprecht B., (1998) Glutathione restoration as indicator for cellular metabolism of astroglial cells. Dev. Neurosci. 20, 401-407.
26. Dringen R., Kranich O., and, Hamprecht B., (1997) The γ-glutamyl transpeptidase inhibitor acivicin preserves glutathione released by astroglial cells in culture. Neurochem. Res. 22, 727-733.
27. Dringen R., Hoepken H. H., Minich T., and, Ruedig C., (2007) Pentose phosphate pathway and NADPH metabolism, in Handbook of Neurochemistry and Molecular Neurobiology (, Dienel G., and, Gibson G. S., eds), pp. 41-62. Neural Energy Utilization, Springer, Heidelberg.
28. Fernandez-Fernandez S., Almeida A., and, Bolaños J. P., (2012) Antioxidant and bioenergetic coupling between neurons and astrocytes. Biochem. J. 443, 3-12.
29. Ferrer I., Lizcano J. M., Hernandez M., and, Unzeta M., (2002) Overexpression of semicarbazide sensitive amine oxidase in the cerebral blood vessels in patients with Alzheimer's disease and cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy. Neurosci. Lett. 321, 21-24.
30. Forneris F., Battaglioli E., Mattevi A., and, Binda C., (2009) New roles of flavoproteins in molecular cell biology: histone demethylase LSD1 and chromatin. FEBS J. 276, 4304-4312.
31. Fountoulakis M., Gulesserian T., and, Lubec G., (2003) Overexpression of C1-tetrahydrofolate synthase in fetal Down syndrome brain. J. Neural Transm. Suppl. 67, 85-93.
32. Franks S. J., (2005) A mathematical model for the absorption and metabolism of formaldehyde vapour by humans. Toxicol. Appl. Pharmacol. 206, 309-320.
33. Friedenson B., (2011) A common environmental carcinogen unduly affects carriers of cancer mutations: carriers of genetic mutations in a specific protective response are more susceptible to an environmental carcinogen. Med. Hypotheses 77, 791-797.
34. Fukuda T., Tokunaga A., Sakamoto R., and, Yoshida N., (2011) Fbxl10/Kdm2b deficiency accelerates neural progenitor cell death and leads to exencephaly. Mol. Cell. Neurosci. 46, 614-624.
35. Galter D., Carmine A., Buervenich S., Duester G., and, Olson L., (2003) Distribution of class I, III and IV alcohol dehydrogenase mRNAs in the adult rat, mouse and human brain. Eur. J. Biochem. 270, 1316-1326.
36. Gennuso F., Fernetti C., Tirolo C., et al,. (2004) Bilirubin protects astrocytes from its own toxicity by inducing up-regulation and translocation of multidrug resistance-associated protein 1 (Mrp1). Proc. Natl Acad. Sci. USA 101, 2470-2475.
37. Grönvall-Nordquist J. L., Backlund L. B., Garpenstrand H., Ekblom J., Landin B., Yu P. H., Oreland L., and, Rosenqvist U., (2001) Follow-up of plasma semicarbazide-sensitive amine oxidase activity and retinopathy in type 2 diabetes mellitus. J. Diabetes Complications 15, 250-256.
38. de Groot A. C., Flyvholm M. A., Lensen G., Menne T., and, Coenraads P. J., (2009) Formaldehyde-releasers: Relationship to formaldehyde contact allergy. Contact allergy to formaldehyde and inventory of formaldehyde-releasers. Contact Derm. 61, 63-85.
39. de Groot A., White I. R., Flyvholm M. A., Lensen G., and, Coenraads P. J., (2010) Formaldehyde-releasers in cosmetics: relationship to formaldehyde contact allergy. Part 2. Patch test relationship to formaldehyde contact allergy, experimental provocation tests, amount of formaldehyde released, and assessment of risk to consumers allergic to formaldehyde. Contact Derm. 62, 18-31.
40. Guo J. M., Liu A. J., Zang P., et al,. (2013) ALDH2 protects against stroke by clearing 4-HNE. Cell Res. 2013, 1-16.
41. Gurel A., Coskun O., Armutcu F., Kante M., and, Ozen O. A., (2005) Vitamin E against oxidative damage caused by formaldehyde in frontal cortex and hippocampus: biochemical and histological studies. J. Chem. Neuroanat. 29, 173-178.
42. Haider L., Fischer M. T., Frischer J. M., Bauer J., Hoftberger R., Botond G., Esterbauer H., Binder C. J., Witztum J. L., and, Lassmann H., (2011) Oxidative damage in multiple sclerosis lesions. Brain 134, 1914-1924.
43. Halim N. D., McFate T., Mohyeldin A., et al,. (2010) Phosphorylation status of pyruvate dehydrogenase distinguishes metabolic phenotypes of cultured rat brain astrocytes and neurons. Glia 58, 1168-1176.
44. Harris C., Wang S. W., Lauchu J. J., and, Hansen J. M., (2003) Methanol metabolism and embryotoxicity in rat and mouse conceptuses: comparisons of alcohol dehydrogenase (ADH1), formaldehyde dehydrogenase (ADH3), and catalase. Reprod. Toxicol. 17, 349-357.
45. Hayami S., Yoshimatsu M., Veerakumarasivam A., et al,. (2010) Overexpression of the JmjC histone demethylase KDM5B in human carcinogenesis: involvement in the proliferation of cancer cells through the E2F/RB pathway. Mol. Cancer 9, 59.
46. Hayami S., Kelly J. D., Cho H. S., et al,. (2011) Overexpression of LSD1 contributes to human carcinogenesis through chromatin regulation in various cancers. Int. J. Cancer 128, 574-586.
47. He R., Lu J., and, Miao J., (2010) Formaldehyde stress. Sci. China Life Sci. 53, 1399-1404.
48. Heck H. D., and, Casanova M., (2004) The implausibility of leukemia induction by formaldehyde: a critical review of the biological evidence on distant-site toxicity. Regul. Toxicol. Pharmacol. 40, 92-106.
49. 2O under controlled conditions. Am. Ind. Hyg. Assoc. J. 46, 1-3.
50. Heck H. D., Casanova M., and, Starr T. B., (1990) Formaldehyde toxicity-new understanding. Crit. Rev. Toxicol. 20, 397-426.
51. Hedberg J. J., Backlund M., Stromberg P., Lonn S., Dahl M. L., Ingelman-Sundberg M., and, Hoog J. O., (2001) Functional polymorphism in the alcohol dehydrogenase 3 (ADH3) promoter. Pharmacogenetics 11, 815-824.
52. Henzi H., (1984) Chronic methanol poisoning with the clinical and pathologic-anatomical features of multiple sclerosis. Med. Hypotheses 13, 63-75.
53. Herrero-Mendez A., Almeida A., Fernández E., Maestre C., Moncada S., and, Bolaños J. P., (2009) The bioenergetic and antioxidant status of neurons is controlled by continuous degradation of a key glycolytic enzyme by APC/C-Cdh1. Nat. Cell Biol. 11, 747-752.
54. van Horssen J., Schreibelt G., Drexhage J., Hazes T., Dijkshtra C. D., van der Valk P., and, de Vries H. E., (2008) Severe oxidative damage in multiple sclerosis lesions coincides with enhanced antioxidant enzyme expression. Free Radic. Biol. Med. 45, 1729-1737.
55. van Horssen J., Witte M. E., Schreibelt G., and, de Vries H. E., (2011) Radical changes in multiple sclerosis pathogenesis. Biochim. Biophys. Acta 1812, 141-150.
56. Hou H., and, Yu H., (2010) Structural insights into histone lysine demethylation. Curr. Opin. Struct. Biol. 20, 739-748.
57. Iborra F. J., Renau-Piqueras J., Portoles M., Boleda M. D., Guerri C., and, Pares X., (1992) Immunocytochemical and biochemical demonstration of formaldehyde dehydrogenase (class III alcohol dehydrogenase) in the nucleus. J. Histochem. Cytochem. 40, 1865-1878.
58. Izzo A., and, Schneider R., (2010) Chatting histone modifications in mammals. Brief. Funct. Genomics 9, 429-443.
59. Jalkanen S., and, Salmi M., (2001) Cell surface monoamine oxidases: enzymes in search of a function. EMBO J. 20, 3893-3901.
60. Jalkanen S., and, Salmi M., (2008) VAP-1 and CD73, endothelial cell surface enzymes in leukocyte extravasation. Arterioscler. Thromb. Vasc. Biol. 28, 18-26.
61. Janáky R., Cruz-Aguado R., Oja S. S., and, Shaw C. A., (2007) Glutathione in the nervous system: roles in neural function and health and implications for neurological disease, in Handbook of Neurochemistry (, Oja S. S., Schousboe A., and, Saransaari P., eds), pp. 347-399. Amino Acids and Peptides in the Nervous System, Springer, Heidelberg.
62. Julia P., Farres J., and, Pares X., (1987) Characterization of three isoenzymes of rat alcohol-dehydrogenase-tissue distribution and physical and enzymatic-properties. Eur. J. Biochem. 162, 179-189.
63. Kahl P., Gullotti L., Heukamp L. C., et al,. (2006) Androgen receptor coactivators lysine-specific histone demethylase 1 and four and a half LIM domain protein 2 predict risk of prostate cancer recurrence. Cancer Res. 66, 11341-11347.
64. Kapur B. M., Vandenbroucke A. C., Adamchik Y., Lehotay D. C., and, Carlen P. L., (2007) Formic acid, a novel metabolite of chronic ethanol abuse, causes neurotoxicity, which is prevented by folic acid. Alcohol. Clin. Exp. Res. 31, 2114-2120.
65. Karadi I., Meszaros Z., Csanyi A., Szombathy T., Hosszufalusi N., Romics L., and, Magyar K., (2002) Serum semicarbazide-sensitive amine oxidase (SSAO) activity is an independent marker of carotid atherosclerosis. Clin. Chim. Acta 323, 139-146.
66. Kato S., Burke P. J., Koch T. H., and, Bierbaum V. M., (2001) Formaldehyde in human cancer cells: detection by preconcentration-chemical ionization mass spectrometry. Anal. Chem. 73, 2992-2997.
67. Keppler D., (2011) Multidrug resistance proteins (MRPs, ABCCs): importance for pathophysiology and drug therapy. Handb. Exp. Pharmacol. 201, 299-323.
68. Khokhlov A. P., Zavalishin I. A., Savchenko I. N., and, Dziuba A. N., (1989) Disorders of formaldehyde metabolism and its metabolic precursors in patients with multiple sclerosis. Zh. Nevropatol. Psikhiatr. Im. S. S. Korsakova 89, 45-48.
69. Kiernan J. A., (2000) Formaldehyde, formalin, paraformaldehyde and glutaraldehyde: what they are and what they do. Microsc. Today 1, 8-12.
70. Kiernan M. C., Vucic S., Cheah B. C., Turner M. R., Eisen A., Hardiman O., Burrell J. R., and, Zoing M. C., (2011) Amyotrophic lateral sclerosis. Lancet 377, 942-955.
71. Kilburn K. H., Seidman B. C., and, Warshaw R., (1985a) Neurobehavioral and respiratory symptoms of formaldehyde and xylene exposure in histology technicians. Arch. Environ. Health 40, 229-233.
72. Kilburn K. H., Warshaw R., Boylen C. T., Johnson S. J., Seidman B., Sinclair R., and, Takaro T. Jr, (1985b) Pulmonary and neurobehavioral effects of formaldehyde exposure. Arch. Environ. Health 40, 254-260.
73. Krupenko S. A., (2009) FDH: an aldehyde dehydrogenase fusion enzyme in folate metabolism. Chem. Biol. Interact. 178, 84-93.
74. Krupenko N. I., Dubard M. E., Strickland K. C., Moxley K. M., Oleinik N. V., and, Krupenko S. A., (2010) ALDH1L2 is the mitochondrial homolog of 10-formyltetrahydrofolate dehydrogenase. J. Biol. Chem. 285, 23056-23063.
75. Kurkijarvi R., Yegutkin G. G., Gunson B. K., Jalkanen S., Salmi M., and, Adams D. H., (2000) Circulating soluble vascular adhesion protein 1 accounts for the increased serum monoamine oxidase activity in chronic liver disease. Gastroenterology 119, 1096-1103.
76. Laitinen J., Makela M., Mikkola J., and, Huttu I., (2010) Fire fighting trainers' exposure to carcinogenic agents in smoke diving simulators. Toxicol. Lett. 192, 61-65.
77. Lee E. S., Chen H., Hardman C., Simm A., and, Charlton C., (2008) Excessive S-adenosyl-L-methionine-dependent methylation increases levels of methanol, formaldehyde and formic acid in rat brain striatal homogenates: possible role in S-adenosyl-L-methionine-induced Parkinson's disease-like disorders. Life Sci. 83, 821-827.
78. Lee M., Schwab C., and, McGeer P. L., (2011) Astrocytes are GABAergic cells that modulate microglial activity. Glia 59, 152-165.
79. Leuner K., Muller W. E., and, Reichert A. S., (2012) From mitochondrial dysfunction to amyloid beta formation: novel insights into the pathogenesis of Alzheimer's disease. Mol. Neurobiol. 46, 186-193.
80. Lewerenz J., Dargusch R., and, Maher P., (2010) Lactacidosis modulates glutathione metabolism and oxidative glutamate toxicity. J. Neurochem. 113, 502-514.
81. Li F., Liu X., Su Z., and, Sun R., (2011) Acidosis leads to brain dysfunctions through impairing cortical GABAergic neurons. Biochem. Biophys. Res. Commun. 410, 775-779.
82. Li F., Gong Q., Dong H., and, Shi J., (2012) Resveratrol, a neuroprotective supplement for Alzheimer's disease. Curr. Pharm. Des. 18, 27-33.
83. Lim S., Janzer A., Becker A., Zimmer A., Schule R., Buettner R., and, Kirfel J., (2010) Lysine-specific demethylase 1 (LSD1) is highly expressed in ER-negative breast cancers and a biomarker predicting aggressive biology. Carcinogenesis 31, 512-520.
84. Lu S. C., (2013) Glutathione synthesis. Biochim. Biophys. Acta 1830, 3143-3153.
85. Lu Z., Li C. M., Qiao Y., Yan Y., and, Yang X., (2008) Effect of inhaled formaldehyde on learning and memory of mice. Indoor Air 18, 77-83.
86. Lu J., Li C., Su T., Liu Y., and, He R., (2013) Formaldehyde induces hyperphosphorylation and polymerization of Tau protein both in vitro and in vivo. Biochim. Biophys. Acta 1830, 4102-4116.
87. Luo F. C., Zhou J., Lv T., Qi L., Wang S. D., Nakamura H., Yodoi J., and, Bai J., (2012) Induction of endoplasmic reticulum stress and the modulation of thioredoxin-1 in formaldehyde-induced neurotoxicity. Neurotoxicology 33, 290-298.
88. Lushchak V. I., (2012) Glutathione homeostasis and functions: potential targets for medical interventions. J. Amino Acids 2012, 736837.
89. MacAllister S. L., Choi J., Dedina L., and, O'Brien P. J., (2011) Metabolic mechanisms of methanol/formaldehyde in isolated rat hepatocytes: Carbonyl-metabolizing enzymes versus oxidative stress. Chem. Biol. Interact. 191, 308-314.
90. MacFarlane A. J., Perry C. A., Girnary H. H., Gao D., Allen R. H., Stabler S. P., Shane B., and, Stover P. J., (2009) Mthfd1 is an essential gene in mice and alters biomarkers of impaired one-carbon metabolism. J. Biol. Chem. 284, 1533-1539.
91. Mahad D., Ziabreva I., Lassmann H., and, Turnbull D., (2008) Mitochondrial defects in acute multiple sclerosis lesions. Brain 131, 1722-1735.
92. Malek F. A., Moritz K. U., and, Fanghanel J., (2003) A study on specific behavioral effects of formaldehyde in the rat. J. Exp. Anim. Sci. 42, 160-170.
93. del Mar Hernandez M., Esteban M., Szabo P., Boada M., and, Unzeta M., (2005) Human plasma semicarbazide sensitive amine oxidase (SSAO), β-amyloid protein and aging. Neurosci. Lett. 384, 183-187.
94. Martinez S. E., Vaglenova J., Sabria J., Martinez M. C., Farres J., and, Pares X., (2001) Distribution of alcohol dehydrogenase mRNA in the rat central nervous system-consequences for brain ethanol and retinoid metabolism. Eur. J. Biochem. 268, 5045-5056.
95. Mason M. J., Mattsson K., Pasternack M., Voipio J., and, Kaila K., (1990) Postsynaptic fall in intracellular pH and increase in surface pH caused by efflux of formate and acetate anions through GABA-gated channels in crayfish muscle-fibers. Neuroscience 34, 359-368.
96. Meinerz D. F., Comprasi B., Allebrandt J., et al,. (2013) Sub-acute administration of (S)-dimethyl 2-(3-(phenyltellanyl) propanamido) succinate induces toxicity and oxidative stress in mice: unexpected effects of N-acetylcysteine. Springerplus 2, 182.
97. Meszaros Z., Szombathy T., Raimondi L., Karadi I., Romics L., and, Magyar K., (1999) Elevated serum semicarbazide-sensitive amine oxidase activity in non-insulin-dependent diabetes mellitus: correlation with body mass index and serum triglyceride. Metabolism 48, 113-117.
98. Metz B., Kersten G. F., Hoogerhout P., et al,. (2004) Identification of formaldehyde-induced modifications in proteins: reactions with model peptides. J. Biol. Chem. 279, 6235-6243.
99. Metz B., Kersten G. F., Baart G. J., de Jong A., Meiring H., ten Hove J., van Steenbergen M. J., Hennink W. E., Crommelin D. J., and, Jiskoot W., (2006) Identification of formaldehyde-induced modifications in proteins: reactions with insulin. Bioconjug. Chem. 17, 815-822.
100. Miao J., and, He R., (2012) Chronic formaldehyde-mediated impairments and age-related dementia, in Neurodegeneration (, Martin L. M., and, Loh S. H. Y., eds), pp. 59-76. InTech, doi: 10.5772/34949.
101. Monte W. C., (2010) Methanol: a chemical Trojan horse as the root of the inscrutable U. Med. Hypotheses 74, 493-496.
102. Moschen I., Broer A., Galic S., Lang F., and, Broer S., (2012) Significance of short chain fatty acid transport by members of the monocarboxylate transporter family (MCT). Neurochem. Res. 37, 2562-2568.
103. Mukherjee S., and, Manahan-Vaughan D., (2013) Role of metabotropic glutamate receptors in persistent forms of hippocampal plasticity and learning. Neuropharmacology 66, 65-81.
104. Nazarian A., Hermannsson B. J., Muller J., Zurakowski D., and, Snyder B. D., (2009) Effects of tissue preservation on murine bone mechanical properties. J. Biomech. 42, 82-86.
105. Neves A., Costalat R., and, Pellerin L., (2012) Determinants of brain cell metabolic phenotypes and energy substrate utilization unraveled with a modeling approach. PLoS Comput. Biol. 8, e1002686.
106. Neymeyer V., Tephly T. R., and, Miller M. W., (1997) Folate and 10-formyltetrahydrofolate dehydrogenase (FDH) expression in the central nervous system of the mature rat. Brain Res. 766, 195-204.
107. Nicholls P., (1975) Formate as an inhibitor of cytochrome c oxidase. Biochem. Biophys. Res. Commun. 67, 610-616.
108. Nishimura M., and, Naito S., (2006) Tissue-specific mRNA expression profiles of human phase I metabolizing enzymes except for cytochrome P450 and phase II metabolizing enzymes. Drug Metab. Pharmacokinet. 21, 357-374.
109. Obata T., (2006) Diabetes and semicarbazide-sensitive amine oxidase (SSAO) activity: a review. Life Sci. 79, 417-422.
110. Obata T., and, Yamanaka Y., (2000) Evidence for existence of immobilization stress-inducible semicarbazide-sensitive amine oxidase inhibitor in rat brain cytosol. Neurosci. Lett. 296, 58-60.
111. Oldham M. C., Konopka G., Iwamoto K., Langfelder P., Kato T., Horvath S., and, Geschwind D., (2008) Functional organization of the transcriptome in the human brain. Nat. Neurosci. 11, 1271-1282.
112. A receptors: subtypes provide diversity of function and pharmacology. Neuropharmacology 56, 141-148.
113. O'Sullivan J., Unzeta M., Healy J., O'Sullivan M. I., Davey G., and, Tipton K. F., (2004) Semicarbazide-sensitive amine oxidases: enzymes with quite a lot to do. Neurotoxicology 25, 303-315.
114. Oyama Y., Sakai H., Arata T., Okano Y., Akaike N., Sakai K., and, Noda K., (2002) Cytotoxic effects of methanol, formaldehyde, and formate on dissociated rat thymocytes: a possibility of aspartame toxicity. Cell Biol. Toxicol. 18, 43-50.
115. Paling D., Golay X., Wheeler-Kingshott C., Kapoor R., and, Miller D., (2011) Energy failure in multiple sclerosis and its investigation using MR techniques. J. Neurol. 258, 2113-2127.
116. Parnetti L., Reboldi G. P., and, Gallai V., (2000) Cerebrospinal fluid pyruvate levels in Alzheimer's disease and vascular dementia. Neurology 54, 735-737.
117. Pauwels P. J., Opperdoes F. R., and, Trouet A., (1985) Effects of antimycin, glucose deprivation, and serum on cultures of neurons, astrocytes, and neuroblastoma cells. J. Neurochem. 44, 143-148.
118. Pitten F. A., Kramer A., Herrmann K., Breme I., and, Koch S., (2000) Formaldehyde neurotoxicity in animal experiments. Pathol. Res. Pract. 196, 193-198.
119. Prasannan P., Pike S., Peng K., Shane B., and, Appling D. R., (2003) Human mitochondrial C1-tetrahydrofolate synthase: gene structure, tissue distribution of the mRNA, and immunolocalization in Chinese hamster ovary cells. J. Biol. Chem. 278, 43178-43187.
120. Regan R. F., and, Guo Y. P., (1999a) Extracellular reduced glutathione increases neuronal vulnerability to combined chemical hypoxia and glucose deprivation. Brain Res. 817, 145-150.
121. Regan R. F., and, Guo Y. P., (1999b) Potentiation of excitotoxic injury by high concentrations of extracellular reduced glutathione. Neuroscience 91, 463-470.
122. Richard T., Pawlus A. D., Iglesias M. L., Pedrot E., Waffo-Teguo P., Merillon J. M., and, Monti J. P., (2011) Neuroprotective properties of resveratrol and derivatives. Ann. N. Y. Acad. Sci. 1215, 103-108.
123. Rose C. F., (2010) Increase brain lactate in hepatic encephalopathy: cause or consequence? Neurochem. Int. 57, 389-394.
124. Ross J. M., Oberg J., Brene S., et al,. (2010) High brain lactate is a hallmark of aging and caused by a shift in the lactate dehydrogenase A/B ratio. Proc. Natl Acad. Sci. USA 107, 20087-20092.
125. Salthammer T., Mentese S., and, Marutzky R., (2010) Formaldehyde in the indoor environment. Chem. Rev. 110, 2536-2572.
126. Sarsilmaz M., Kaplan S., Songur A., Colakoglu S., Aslan H., Tunc A. T., Ozen Q. A., Turgut M., and, Bas O., (2007) Effects of postnatal formaldehyde exposure on pyramidal cell number, volume of cell layer in hippocampus and hemisphere in the rat: a stereological study. Brain Res. 1145, 157-167.
127. Sasseville D., (2004) Hypersensitivity to preservatives. Dermatol. Ther. 17, 251-263.
128. Schad A., Fahimi H. D., Volkl A., and, Baumgart E., (2003) Expression of catalase mRNA and protein in adult rat brain: detection by nonradioactive in situ hybridization with signal amplification by catalyzed reporter deposition (ISH-CARD) and immunohistochemistry (IHC)/immunofluorescence (IF). J. Histochem. Cytochem. 51, 751-760.
129. Scheiber I. F., and, Dringen R., (2011) Copper accelerates glycolytic flux in cultured astrocytes. Neurochem. Res. 36, 894-903.
130. Schildhaus H. U., Riegel R., Hartmann W., et al,. (2011) Lysine-specific demethylase 1 is highly expressed in solitary fibrous tumors, synovial sarcomas, rhabdomyosarcomas, desmoplastic small round cell tumors, and malignant peripheral nerve sheath tumors. Hum. Pathol. 42, 1667-1675.
131. Schmidt M. M., and, Dringen R., (2012) GSH synthesis and metabolism, in Advances in Neurobiology (, Gruetter R., and, Choi I. Y., eds), pp. 1029-1050. Neural Metabolism in vivo, Springer, New York.
132. Schulte J. H., Lim S., Schramm A., et al,. (2009) Lysine-specific demethylase 1 is strongly expressed in poorly differentiated neuroblastoma: implications for therapy. Cancer Res. 69, 2065-2071.
133. Schwyzer R. U., and, Henzi H., (1983) Multiple sclerosis: plaques caused by 2-step demyelination? Med. Hypotheses 12, 129-142.
134. Skrzydlewska E., (2003) Toxicological and metabolic consequences of methanol poisoning. Toxicol. Mech. Methods 13, 277-293.
135. Smith D. J., and, Vainio P. J., (2007) Targeting vascular adhesion protein-1 to treat autoimmune and inflammatory diseases. Ann. N. Y. Acad. Sci. 1110, 382-388.
136. Sohal R. S., and, Orr W. C., (2012) The redox stress hypothesis of aging. Free Radic. Biol. Med. 52, 539-555.
137. Song M. S., Baker G. B., Dursun S. M., and, Todd K. G., (2010) The antidepressant phenelzine protects neurons and astrocytes against formaldehyde-induced toxicity. J. Neurochem. 114, 1405-1413.
138. Songur A., Sarsilmaz M., Ozen O. A., Sahin S., Koken R., Zararsiz I., and, Ilhan N., (2008) The effects of inhaled formaldehyde on oxidant and antioxidant systems of rat cerebellum during the postnatal development process. Toxicol. Mech. Methods 18, 569-574.
139. Songur A., Ozen O. A., and, Sarsilmaz M., (2010) The toxic effects of formaldehyde on the nervous system. Rev. Environ. Contam. Toxicol. 203, 105-118.
140. Sorg B. A., Swindell S., and, Tschirgi M. L., (2004) Repeated low level formaldehyde exposure produces enhanced fear conditioning to odor in male, but not female, rats. Brain Res. 1008, 11-19.
141. Staab C. A., Alander J., Morgenstern R., Grafstrom R. C., and, Hoog J. O., (2009) The janus face of alcohol dehydrogenase 3. Chem. Biol. Interact. 178, 29-35.
142. Staub F., Peters J., Kempski O., Schneider G. H., Schurer L., and, Baethmann A., (1993) Swelling of glial cells in lactacidosis and by glutamate: significance of Cl-transport. Brain Res. 610, 69-74.
143. Steele M. L., and, Robinson S. R., (2012) Reactive astrocytes give neurons less support: implications for Alzheimer's disease. Neurobiol. Aging 33, 423.e1-423.e13.
144. Steullet P., Cabungcal J. H., Kulak A., Kraftsik R., Chen Y., Dalton T. P., Cuenod M., and, Do K. Q., (2010) Redox dysregulation affects the ventral but not dorsal hippocampus: impairment of parvalbumin neurons, gamma oscillations, and related behaviors. J. Neurosci. 30, 2547-2558.
145. Stewart M. J., Malek K., and, Crabb D. W., (1996) Distribution of messenger RNAs for aldehyde dehydrogenase 1, aldehyde dehydrogenase 2, and aldehyde dehydrogenase 5 in human tissues. J. Investig. Med. 44, 42-46.
146. Sullivan P. G., and, Brown M. R., (2005) Mitochondrial aging and dysfunction in Alzheimer's disease. Prog. Neuropsychopharmacol. Biol. Psychiatry 29, 407-410.
147. Suzuki A., Stern S. A., Bozdagi O., Huntley G. W., Walker R. H., Magistretti P. J., and, Alberini C. M., (2011) Astrocyte-neuron lactate transport is required for long-term memory formation. Cell 144, 810-823.
148. Tang X., Bai Y., Duong A., Smith M. T., Li L., and, Zhang L., (2009) Formaldehyde in China: production, consumption, exposure levels, and health effects. Environ. Int. 35, 1210-1224.
149. Tang X. Q., Ren Y. K., Chen R. Q., et al,. (2011) Formaldehyde induces neurotoxicity to PC12 cells involving inhibition of paraoxonase-1 expression and activity. Clin. Exp. Pharmacol. Physiol. 38, 208-214.
150. Tang X. Q., Ren Y. N., Zhou C. F., et al,. (2012) Hydrogen sulfide prevents formaldehyde-induced neurotoxicity to PC12 cells by attenuation of mitochondrial dysfunction and pro-apoptotic potential. Neurochem. Int. 61, 16-24.
151. Teng S., Beard K., Pourahmad J., Moridani M., Easson E., Poon R., and, O'Brien P. J., (2001) The formaldehyde metabolic detoxification enzyme systems and molecular cytotoxic mechanism in isolated rat hepatocytes. Chem. Biol. Interact. 130-132, 285-296.
152. Tephly T. R., (1991) The toxicity of methanol. Life Sci. 48, 1031-1041.
153. Thigpen A. E., West M. G., and, Appling D. R., (1990) Rat C1-tetrahydrofolate synthase. cDNA isolation, tissue-specific levels of the mRNA, and expression of the protein in yeast. J. Biol. Chem. 265, 7907-7913.
154. Thompson C. M., Ceder R., and, Grafstrom R. C., (2010) Formaldehyde dehydrogenase: beyond phase I metabolism. Toxicol. Lett. 193, 1-3.
155. Tibbetts A. S., and, Appling D. R., (2010) Compartmentalization of mammalian folate-mediated one-carbon metabolism. Annu. Rev. Nutr. 30, 57-81.
156. Tong Z., Luo W., Wang Y., et al,. (2010) Tumor tissue-derived formaldehyde and acidic microenvironment synergistically induce bone cancer pain. PLoS ONE 5, e10234.
157. Tong Z., Zhang J., Luo W., et al,. (2011) Urine formaldehyde level is inversely correlated to mini mental state examination scores in senile dementia. Neurobiol. Aging 32, 31-41.
158. Tong Z., Han C., Luo W., Wang X., Li H., Luo H., Zhou J., Qi J., and, He R., (2013a) Accumulated hippocampal formaldehyde induces age-dependent memory decline. Age (Dordr.) 35, 583-596.
159. Tong Z., Han C., Luo W., et al,. (2013b) Aging-associated excess formaldehyde leads to spatial memory deficits. Sci. Rep. 3, 1807.
160. Tulpule K., and, Dringen R., (2011) Formaldehyde stimulates Mrp1-mediated glutathione deprivation of cultured astrocytes. J. Neurochem. 116, 626-635.
161. Tulpule K., and, Dringen R., (2012) Formate generated by cellular oxidation of formaldehyde accelerates the glycolytic flux in cultured astrocytes. Glia 60, 582-593.
162. Tulpule K., Schmidt M. M., Boecker K., Goldbaum O., Richter-Landsberg C., and, Dringen R., (2012) Formaldehyde induces rapid glutathione export from viable oligodendroglial OLN-93 cells. Neurochem. Int. 61, 1302-1313.
163. Tulpule K., Hohnholt M. C., and, Dringen R., (2013) Formaldehyde metabolism and formaldehyde-induced stimulation of lactate production and glutathione export in cultured neurons. J. Neurochem. 125, 260-272.
164. Turkoglu A. O., Sarsilmaz M., Ogeturk M., Kus I., and, Songur A., (2008) Beneficial effects of caffeic acid phenethyl ester on formaldehyde-induced learning and memory disabilities: a labyrinth test performance study. Erciyes Med. J. 30, 211-217.
165. Tyihák E., and, Király-Véghely Z., (2008) Interaction of trans-resveratrol with endogenous formaldehyde as one basis of
166. Unzeta M., Sole M., Boada M., and, Hernandez M., (2007) Semicarbazide-sensitive amine oxidase (SSAO) and its possible contribution to vascular damage in Alzheimer's disease. J. Neural Transm. 114, 857-862.
167. Uotila L., (1981) Thioesters of glutathione. Methods Enzymol. 77, 424-430.
168. Usanmaz S. E., Akarsu E. S., and, Vural N., (2002) Neurotoxic effects of acute and subacute formaldehyde exposures in mice. Environ. Toxicol. Pharmacol. 11, 93-100.
169. Valente T., Gella A., Sole M., Durany N., and, Unzeta M., (2012) Immunohistochemical study of semicarbazide-sensitive amine oxidase/vascular adhesion protein-1 in the hippocampal vasculature: pathological synergy of Alzheimer's disease and diabetes mellitus. J. Neurosci. Res. 90, 1989-1996.
170. Velez-Fort M., Audinat E., and, Angulo M. C., (2011) Central role of GABA in neuron-glia interactions. Neuroscientist 18, 237-250.
171. Wallace K. B., Eells J. T., Madeira V. M., Cortopassi G., and, Jones D. P., (1997) Mitochondria-mediated cell injury. Symposium overview. Fundam. Appl. Toxicol. 38, 23-37.
172. Wang R. S., Nakajima T., Kawamoto T., and, Honma T., (2002) Effects of aldehyde dehydrogenase-2 genetic polymorphisms on metabolism of structurally different aldehydes in human liver. Drug Metab. Dispos. 30, 69-73.
173. Wang E. Y., Gao H. F., Salter-Cid L., Zhang J., Huang L., Podar E. M., Miller A., Zhao J. J., O'Rourke A., and, Linnik M. D., (2006) Design, synthesis and biological evaluation of semicarbazide-sensitive amine oxidase (SSAO) inhibitors with anti-inflammatory activity. J. Med. Chem. 49, 2166-2173.
174. Weisskopf M. G., Morozova N., O'Reilly E. J., McCullough M. L., Calle E. E., Thun M. J., and, Ascherio A., (2009) Prospective study of chemical exposures and amyotrophic lateral sclerosis. J. Neurol. Neurosurg. Psychiatry 80, 558-561.
175. Wolf S. S., Patchev V. K., and, Obendorf M., (2007) A novel variant of the putative demethylase gene, s-JMJD1C, is a coactivator of the AR. Arch. Biochem. Biophys. 460, 56-66.
176. Xiang Y., Zhu Z., Han G., et al,. (2007) JARID1B is a histone H3 lysine 4 demethylase up-regulated in prostate cancer. Proc. Natl Acad. Sci. USA 104, 19226-19231.
177. Yin J., and, Zhang J., (2011) Multidrug resistance-associated protein 1 (MRP1/ABCC1) polymorphism: from discovery to clinical application. J. Cent. South Univ. 36, 927-938.
178. Yu P. H., (2001) Involvement of cerebrovascular semicarbazide-sensitive amine oxidase in the pathogenesis of Alzheimer's disease and vascular dementia. Med. Hypotheses 57, 175-179.
179. Yu P. H., Wright S., Fan E. H., Lun Z. R., and, Gubisne-Harberle D., (2003) Physiological and pathological implications of semicarbazide-sensitive amine oxidase. Biochim. Biophys. Acta 1647, 193-199.
180. Zararsiz I., Kus I., Akpolat N., Songur A., Ogeturk M., and, Sarsilmaz M., (2006) Protective effects of ω-3 essential fatty acids against formaldehyde-induced neuronal damage in prefrontal cortex of rats. Cell Biochem. Funct. 24, 237-244.
181. Zararsiz I., Kus I., Ogeturk M., Akpolat N., Kose E., Meydan S., and, Sarsilmaz M., (2007) Melatonin prevents formaldehyde-induced neurotoxicity in prefrontal cortex of rats: An immunohistochemical and biochemical study. Cell Biochem. Funct. 25, 413-418.
182. Zararsiz I., Meydan S., Sarsilmaz M., Songur A., Ozen O. A., and, Sogut S., (2011) Protective effects of omega-3 essential fatty acids against formaldehyde-induced cerebellar damage in rats. Toxicol. Ind. Health 27, 489-495.
183. Zhang Y. Z., Zhang Q. H., Ye H., Zhang Y., Luo Y. M., Ji X. M., and, Su Y. Y., (2010) Distribution of lysine-specific demethylase 1 in the brain of rat and its response in transient global cerebral ischemia. Neurosci. Res. 68, 66-72.
184. Zhao H., Cai Y., Yang Z., He D., and, Shen B., (2011) Acidosis leads to neurological disorders through overexciting cortical pyramidal neurons. Biochem. Biophys. Res. Commun. 415, 224-228.
185. Zibetti C., Adamo A., Binda C., Forneris F., Toffolo E., Verpelli C., Ginelli E., Mattevi A., Sala C., and, Battaglioli E., (2010) Alternative splicing of the histone demethylase LSD1/KDM1 contributes to the modulation of neurite morphogenesis in the mammalian nervous system. J. Neurosci. 30, 2521-2532.
186. Zimatkin S. M., and, Lindros K. O., (1996) Distribution of catalase in rat brain: aminergic neurons as possible targets for ethanol effects. Alcohol Alcohol. 31, 167-174.